Patients with out-of-hospital cardiac arrest (OHCA) with shockable rhythm who received epinephrine within 4 minutes of a first defibrillator shock had better outcomes than those who received ...
ABSTRACT: The use of nebulized racemic epinephrine to improve ventilatory function in the newborn postextubation was studied. Forty-five infants intubated for more than 3 days were randomized to ...
BEFORE the advent of the sulfonamides, recovery from the Waterhouse–Friderichsen syndrome was rare. 1 Thereafter, isolated case reports described successful treatment of this fulminating infection, ...
The use of epinephrine, also known as adrenaline, during an out-of-hospital cardiac arrest (OHCA) offered a slight improvement in survival to 30 days but this was offset by worse neurological function ...
In a recent study by Tanimoto and colleagues, neffy produced pharmacodynamic results that were comparable with or higher than autoinjectors and manual injection, including more efficient increases in ...
People who experience out-of-hospital cardiac arrest (OHCA) are most likely to live, and to do so with less disability, when they receive epinephrine within the first 5 minutes of emergency medical ...
The Food and Drug Administration approved the first needle-free alternative to the EpiPen on Friday, a single-use epinephrine nasal spray for the emergency treatment of allergic reactions, including ...
Please provide your email address to receive an email when new articles are posted on . The number of children who received repeat epinephrine dropped as time passed since the first dose. About 95% of ...
A committee of the Food and Drug Administration's outside advisers voted Thursday in favor of an epinephrine nasal spray product, clearing a key hurdle for what could soon be the first needle-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback